Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY scoreBernhard Scheiner, Matthias Pinter, Marc Stadler et al.|Journal of Hepatology|2021Cited by 309
The tumour microenvironment and immune milieu of cholangiocarcinomaLuca Fabris, Mario Strazzabosco, María J. Perugorria et al.|Liver International|2019Cited by 194
The Importance of Molecular Testing in the Treatment of CholangiocarcinomaDavid Malka, Peter Schirmacher, Alexander Siebenhüner et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2020Cited by 3
Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant CenterFatih Karbeyaz, Alexander Siebenhüner, Seraphina Kissling et al.|Journal of Hepatocellular Carcinoma|2021Cited by 2
Validation of the CRAFITY score in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumabBernhard Scheiner, Matthias Pinter, Riccardo Sartoris et al.|Journal of Hepatology|2023Cited by 0